Sort   by:  
 Page size 
UnknownEfficacy of a Low-Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double-Blind, Placebo-Controlled Trial.
Not available
S-EPMC8003468 | biostudies-literature
UnknownTreatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens.
Not available
S-EPMC8079718 | biostudies-literature
UnknownFlow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.
Not available
S-EPMC4482505 | biostudies-literature
UnknownCD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.
Not available
S-EPMC11247362 | biostudies-literature
UnknownNetwork meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.
Not available
S-EPMC10084226 | biostudies-literature
UnknownModeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort.
Not available
S-EPMC5765396 | biostudies-literature
UnknownMeasurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.
Not available
S-EPMC12310548 | biostudies-literature
UnknownOutcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients.
Not available
S-EPMC11761902 | biostudies-literature
UnknownEfficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study.
Not available
S-EPMC11789454 | biostudies-literature
UnknownReal-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.
Not available
S-EPMC12554896 | biostudies-literature
Sort   by:  
 Page size